LENVATINIB vs LERCANIDIPINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LENVATINIB vs LERCANIDIPINE: Safety Overview
| Metric | LENVATINIB | LERCANIDIPINE |
|---|---|---|
| Total FAERS Reports | 33,766 | 3,767 |
| Deaths Reported | 4,449 | 248 |
| Death Rate | 13.2% | 6.6% |
| Hospitalizations | 19,975 | 2,249 |
| Average Patient Age | 65.4 yrs | 65.8 yrs |
| % Female Patients | 55.8% | 47.8% |
| FDA Approval Date | Feb 13, 2015 | N/A |
| Manufacturer | Eisai Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |